New 'Stand Together for AD' Campaign Provides Strength, Support and Important Resources for 11 Million Alzheimer's Caregivers

EAST HANOVER, N.J., Nov. 17, 2010 /PRNewswire/ -- More than five million people in the United States (U.S.) have Alzheimer's disease (AD), a progressive and devastating condition that also impacts millions of more people who love and care for these patients. Last year in the U.S., the 11 million unpaid caregivers for patients with Alzheimer's or another dementia provided 12.5 billion hours of care. While caregiving can be rewarding, it also can be a long and difficult journey, which often affects work, finances, relationships and health. To help caregivers navigate the challenges of this journey, Novartis Pharmaceuticals Corporation has partnered with Leeza Gibbons, Alzheimer's caregiving advocate and TV and radio personality, to create a new educational campaign called "Stand Together for AD: Strength and Support for Alzheimer's," which includes important information, resources and access to a new caregiver support program at www.AlzheimersDisease.com.

Research shows caregivers have a high risk of poor health. Caregivers often experience high levels of depression, new hypertension and new coronary heart disease. The stress of family caregiving for people with dementia has been shown to impact a person's immune system for up to three years after their caregiving ends, increasing their chances of developing a chronic illness themselves. Many caregivers have to downsize work hours or leave their jobs due to caregiving responsibilities, and 39 percent say they have strained marriages due to caregiving responsibilities.

"As my mother died in slow motion from Alzheimer's disease, my family and I were depleted and often depressed. We cared for my mom for nearly ten years and as she battled Alzheimer's, we battled isolation, frustration and fear. Watching her decline felt like an emotional, physical and spiritual assault, which every member of my family dealt with individually," said Leeza Gibbons. "I learned a lot from the experience and know that being a caregiver is not something you can do alone. The mission of 'Stand Together for AD' is close to my heart because it will educate Alzheimer's caregivers and empower them to seek and accept the support they need to get through their difficult and brave journey."

Caregiving is a responsibility that requires strength and support as the progressive disease robs loved ones of memories, energy, and freedom; caregivers may be too overwhelmed, frustrated, or depressed to seek out the help they need. Many more people will become caregivers in the coming years, as the number of Americans with AD is expected to increase significantly.

"Any type of caregiving, especially for people with Alzheimer's, can have a serious physical and emotional effect.  I can't emphasize enough the importance of caregivers seeking out help to cope and making sure they attend to their own health as well," said James E. Galvin, MD, MPH, Professor of Neurology and Psychiatry at the NYU Langone Medical Center and Director of the Pearl S Barlow Center for Memory Evaluation and Treatment.  "Caregivers play a critical role and should also feel empowered to speak to their loved ones' healthcare providers with any questions or concerns about caring for someone with Alzheimer's.  It's important to have open discussions to maintain the well-being of the caregiver and health of the patient." 

Caregivers can visit www.AlzheimersDisease.com for more information about the "Stand Together for AD" educational campaign, AD and caregiving, and resources including tips on coping and staying healthy, access to a new caregiver support program, and stories from fellow Alzheimer's caregivers. Those who register on the site will also receive Leeza's personal caregiving tips.  

About Leeza Gibbons

Leeza Gibbons is an award-winning television and radio personality, author, producer and businesswoman. She recently co-authored Take Your Oxygen First, a book for those giving care to people with Alzheimer's disease and other memory loss disorders. Leeza was a caregiver to her mother and founded the Leeza Gibbons Memory Foundation and Leeza's Place, which provide support for caregivers, in her mother's honor. There are now eight Leeza's Place centers across the United States, with locations in California, Florida, Illinois and Texas.

About Novartis

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group's continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100.000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "will," "can," or similar expressions, or by express or implied discussions regarding potential future revenues which may be earned by Novartis Group companies. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Novartis Group companies will achieve any particular levels of revenue in the future. In particular, management's expectations could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

SOURCE Novartis Pharmaceuticals Corporation